Monday, September 23, 2019

Do the costs of cancer drugs receive enough attention?

A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement.

from Latest Science News -- ScienceDaily https://ift.tt/2m6Vlkz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reverse liver cell aging and cut Alzheimer’s-linked protein in half

A surprising discovery suggests that rejuvenating the liver could help protect against Alzheimer’s disease and heart disease. USC researcher...